Works matching AU Pang, See-Tong

Results: 81
    1

    Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 5, p. 441, doi. 10.1093/jjco/hyac015
    By:
    • Matsubara, Nobuaki;
    • Nishimura, Kazuo;
    • Kawakami, Satoru;
    • Joung, Jae Young;
    • Uemura, Hiroji;
    • Goto, Takayuki;
    • Kwon, Tae Gyun;
    • Sugimoto, Mikio;
    • Kato, Masashi;
    • Wang, Shian-Shiang;
    • Pang, See-Tong;
    • Chen, Chung-Hsin;
    • Fujita, Tomoko;
    • Nii, Masahiro;
    • Shen, Liji;
    • Dujka, Melanie;
    • Hussain, Maha;
    • Bono, Johann de
    Publication type:
    Article
    2
    3
    4
    5
    6

    Identifying cancer origin using circulating tumor cells.

    Published in:
    Cancer Biology & Therapy, 2016, v. 17, n. 4, p. 430, doi. 10.1080/15384047.2016.1141839
    By:
    • Lu, Si-Hong;
    • Tsai, Wen-Sy;
    • Chang, Ying-Hsu;
    • Chou, Teh-Ying;
    • Pang, See-Tong;
    • Lin, Po-Hung;
    • Tsai, Chun-Ming;
    • Chang, Ying-Chih
    Publication type:
    Article
    7
    8

    Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.

    Published in:
    Molecular Oncology, 2014, v. 8, n. 8, p. 1575, doi. 10.1016/j.molonc.2014.06.009
    By:
    • Hsu, Cheng-Lung;
    • Liu, Jai-Shin;
    • Wu, Po-Long;
    • Guan, Hong-Hsiang;
    • Chen, Yuh-Ling;
    • Lin, An-Chi;
    • Ting, Huei-Ju;
    • Pang, See-Tong;
    • Yeh, Shauh-Der;
    • Ma, Wen-Lung;
    • Chen, Chung-Jung;
    • Wu, Wen-Guey;
    • Chang, Chawnshang
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer.

    Published in:
    Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14617
    By:
    • Shao, I-Hung;
    • Chang, Tzu-Hsuan;
    • Chang, Ying-Hsu;
    • Hsieh, Yu-Hsin;
    • Sheng, Ting-Wen;
    • Wang, Li-Jen;
    • Chien, Yu-Hsuan;
    • Huang, Liang-Kang;
    • Chu, Yuan-Cheng;
    • Kan, Hung-Cheng;
    • Lin, Po-Hung;
    • Yu, Kai-Jie;
    • Hsieh, Ming-Li;
    • Chuang, Cheng-Keng;
    • Wu, Chun-Te;
    • Hsieh, Chin-Hsuan;
    • Pang, See-Tong
    Publication type:
    Article
    40
    41

    Preoperative ECOG performance status as a predictor of outcomes in upper tract urothelial cancer surgery.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-95128-1
    By:
    • Yang, Tsung-Mu;
    • Chen, I-Hsuan Alan;
    • Yu, Chia-Cheng;
    • Yang, Chi-Rei;
    • Chen, Wen-Chi;
    • Lin, Po-Hung;
    • Pang, See-Tong;
    • Huang, Steven Kuan-Hua;
    • Chen, Zhi‐Hao;
    • Tseng, Jen-Shu;
    • Lin, Wun-Rong;
    • Tsai, Yao-Chou;
    • Yu, Chih-Chin;
    • Chen, Pi-Che;
    • Cheong, Ian-Seng;
    • Jiang, Yuan-Hong;
    • Wu, Chia-Chang;
    • Huang, Hsu-Che;
    • Tai, Ting-En;
    • Tsai, Chung-You
    Publication type:
    Article
    42

    Preoperative ECOG performance status as a predictor of outcomes in upper tract urothelial cancer surgery.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-95128-1
    By:
    • Yang, Tsung-Mu;
    • Chen, I-Hsuan Alan;
    • Yu, Chia-Cheng;
    • Yang, Chi-Rei;
    • Chen, Wen-Chi;
    • Lin, Po-Hung;
    • Pang, See-Tong;
    • Huang, Steven Kuan-Hua;
    • Chen, Zhi‐Hao;
    • Tseng, Jen-Shu;
    • Lin, Wun-Rong;
    • Tsai, Yao-Chou;
    • Yu, Chih-Chin;
    • Chen, Pi-Che;
    • Cheong, Ian-Seng;
    • Jiang, Yuan-Hong;
    • Wu, Chia-Chang;
    • Huang, Hsu-Che;
    • Tai, Ting-En;
    • Tsai, Chung-You
    Publication type:
    Article
    43
    44

    Long‐term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy‐naïve patients with metastatic castration‐resistant prostate cancer.

    Published in:
    International Journal of Cancer, 2023, v. 152, n. 6, p. 1191, doi. 10.1002/ijc.34348
    By:
    • Chen, Hung‐Kai;
    • Su, Po‐Jung;
    • Wang, Yan‐Lin;
    • Chang, Kai‐Cheng;
    • Su, Yu‐Li;
    • Chang, Pei‐Hung;
    • Kuan, Feng‐Che;
    • Hsieh, Chia‐Hsun;
    • Kuo, Yung‐Chia;
    • Sheng, Ting‐Wen;
    • Chang, Ching‐Fu;
    • Yu, Shao‐Ming;
    • Huang, Wen‐Kuan;
    • Lin, Yung‐Chang;
    • Tsan, Din‐Li;
    • Yu, Kai‐Jie;
    • Lin, Po‐Hung;
    • Chen, Hui‐Yu;
    • Chang, Ying‐Hsu;
    • Pang, See‐Tong
    Publication type:
    Article
    45
    46
    47
    48
    49
    50

    Gonadotropin‐releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin‐releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study.

    Published in:
    Prostate, 2021, v. 81, n. 12, p. 902, doi. 10.1002/pros.24187
    By:
    • Chen, Dong‐Yi;
    • Su, Po‐Jung;
    • See, Lai‐Chu;
    • Liu, Jia‐Rou;
    • Chuang, Cheng‐Keng;
    • Pang, See‐Tong;
    • Tseng, Chi‐Nan;
    • Chen, Shao‐Wei;
    • Hsieh, I‐Chang;
    • Chu, Pao‐Hsien;
    • Lin, Yung‐Chang;
    • Hsu, Cheng‐Lung;
    • Chang, John Wen‐Cheng;
    • Lin, Miao‐Sui;
    • Pang, Jong‐Hwei S.;
    • Hsieh, Ming‐Jer;
    • Huang, Wen‐Kuan
    Publication type:
    Article